HARP - FDA approves Merck's Keytruda for FIGO 2014 cervical cancer
2024-01-12 18:09:53 ET
More on Merck
- Merck & Co., Inc. (MRK) JPMorgan 42nd Annual Healthcare Conference (Slides)
- Merck & Co., Inc. (MRK) Presents at JPMorgan 42nd Annual Healthcare Conference (Transcript)
- Merck's Soaring Stock: Examining The Euphoria Amidst Potential Pitfalls
- Harpoon Therapeutics could see interest from other parties, Oppenheimer says
- Merck on track to snap its seven-day win streak
For further details see:
FDA approves Merck's Keytruda for FIGO 2014 cervical cancer